Exhbit 15.2


                   AWARENESS LETTER OF INDEPENDENT ACCOUNTANTS





November 15, 1998



Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549


Re:     ICN Pharmaceuticals, Inc.
        Registrations on Form S-8 (File No. 33-56971), Form S-4 (File No. 
        333-63721) and Form S-3(File Nos. 333-10661 and 333-49665)


We are aware that our report  dated  November 9, 1998,  on our review of interim
financial information of ICN Pharmaceuticals,  Inc. for the three and nine month
periods ended September 30, 1998 and included in the Company's  quarterly report
on Form 10-Q for the  period  then ended is  incorporated  by  reference  in the
Registrations on Form S-8 (File No. 33-56971), Form S-4 (File No. 333-63721) and
on Form S-3 (File Nos.  333-10661 and 333-49665).  Pursuant to Rule 436(c) under
the Securities  Act of 1933,  this report should not be considered a part of the
registration  statement  prepared  or  certified  by us within  the  meaning  of
Sections 7 and 11 of that Act.

/S/  PRICEWATERHOUSECOOPERS LLP

PricewaterhouseCoopers LLP
Newport Beach, California